http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72b6cdf1c6426a79eb5e05cbd4c1fafc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cross |
| name | Nicholas CP Cross Nicholas C.P. Cross Nicholas C.P Cross |
| given-name | Nicholas CP Nicholas C.P. Nicholas C.P |
| organization-name | National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Odstock, Salisbury, Wiltshire, United Kingdom 13Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; and; 14Human Genetics Division, University of Southampton, Southampton, United Kingdom From the Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, UK; the Dana Farber Cancer Institute, Boston, MA; the Hospital Geral de Santo António, Oporto, Portugal; the Hospital Universitario de Salamanca, Salamanca, Spain; and the Norfolk and Norwich Hospital, Norwich, UK. Faculty of Medicine University of Southampton Southampton United Kingdom; Wessex Regional Genetics Laboratory Salisbury United Kingdom Department of Haematology; Imperial College School of Medicine; Hammersmith Hospital; London, UK National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, UK Katerina Zoi, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Nicholas C.P. Cross, Salisbury District Hospital, Salisbury; and University of Southampton, Southampton, United Kingdom. National Genetics Reference Laboratory (Wessex), Salisbury, UK Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Wessex Regional Genetics Laboratory, Salisbury Hospital, Salisbury, United Kingdom. Wessex Regional Genetics Laboratory, Salisbury, United Kingdom; University of Southampton, Southampton, United Kingdom From the Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, UK; and Clinica Pediatrica Università di Milano, Ospedale San Gerardo, Monza, Italy. From the Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA; LRF Centre For Adult Leukaemia, Royal Postgraduate Medical School, Hammersmith Hospital, London; and Department of Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom. Faculty of Medicine University of Southampton Southampton UK; Wessex Regional Genetics Laboratory Salisbury UK Authors' Affiliation: Wessex Regional Genetics Laboratory, Salisbury, and Human Genetics Division, University of Southampton Faculty of Medicine, Southampton, United Kingdom Wessex Regional Genetics Laboratory Salisbury UK; Faculty of Medicine University of Southampton Southampton UK National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Odstock, Salisbury, Wiltshire, United Kingdom. From the Cancer Research Campaign Laboratories, Department of Cancer Medicine, Imperial College School of Medicine; Department of Surgery, Charing Cross Hospital; and Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom. Faculty of Medicine University of Southampton Southampton United Kingdom Wessex Regional Genetics Laboratory University of Southampton, Salisbury District Hospital Salisbury United Kingdom; Faculty of Medicine University of Southampton Southampton United Kingdom From the Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, UK; and the Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA. Raphaël Itzykson, Margot Morabito, Olivier A. Bernard, William Vainchenker, Nathalie Droin, Eric Solary, Institut Gustave Roussy, Villejuif; Raphaël Itzykson, Margot Morabito, William Vainchenker, Nathalie Droin, Eric Solary, Université Paris-Sud, Le Kremlin-Bicêtre, Orsay; Olivier Kosmider, François Dreyfus, Michaela Fontenay, Assistance Publique–Hôpitaux de Paris, Hôpital Cochin; Olivier Kosmider, François Dreyfus, Michaela Fontenay, Université Paris Descartes; Olivier Kosmider, Michaela Fontenay,... |
Incoming Links
Total number of triples: 104.